This grant is for establishing Centers for Accelerating Phage Therapy (CAPT-CEP) specifically aimed at combating ESKAPE Pathogens. These new Centers will be crucial for advancing robust phage therapy research and development by focusing on key areas. They are expected to develop innovative preclinical assays, essential tools, and effective models that are vital for successful R&D in bacteriophage therapy. Furthermore, a significant objective of this funding is to progress phage clinical research, moving promising therapies closer to patient application. The overall goal is to enhance the scientific foundation and practical applications of bacteriophage-based treatments to address the critical threat posed by ESKAPE pathogens, which are notoriously difficult to treat with conventional antibiotics.
Opportunity ID: 356813
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-24-069 |
| Funding Opportunity Title: | Centers for Accelerating Phage (Bacteriophage) Therapy to Combat ESKAPE Pathogens (CAPT-CEP) (P01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 23, 2024 |
| Last Updated Date: | Oct 23, 2024 |
| Original Closing Date for Applications: | Jan 28, 2025 |
| Current Closing Date for Applications: | Jan 28, 2025 |
| Archive Date: | Mar 05, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $1,200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Native American tribal governments (Federally recognized) County governments Independent school districts Private institutions of higher education Public housing authorities/Indian housing authorities Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education City or township governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this notice of funding opportunity (NOFO) is to solicit applications to establish Centers for Accelerating Phage Therapy to Combat ESKAPE Pathogens (CAPT-CEP). These Centers will focus on developing preclinical assays, tools, and models for robust phage therapy research and development (R and D) and advancing phage clinical research. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-069.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 356813 Full Announcement-RFA-AI-24-069 -> RFA-AI-24-069-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00288176 | Dec 18, 2024 | Dec 19, 2024 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289711 | Dec 27, 2024 | Jan 28, 2025 | View |
Package 1
Mandatory forms
356813 RR_SF424_5_0-5.0.pdf
356813 PHS398_CoverPageSupplement_5_0-5.0.pdf
356813 RR_OtherProjectInfo_1_4-1.4.pdf
356813 PerformanceSite_4_0-4.0.pdf
356813 RR_KeyPersonExpanded_4_0-4.0.pdf
356813 PHS398_ResearchPlan_5_0-5.0.pdf
356813 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
356813 PHS_Additional_IndirectCosts_2_0-2.0.pdf
356813 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
356813 RR_SF424_5_0-5.0.pdf
356813 PHS398_CoverPageSupplement_5_0-5.0.pdf
356813 RR_OtherProjectInfo_1_4-1.4.pdf
356813 PerformanceSite_4_0-4.0.pdf
356813 RR_KeyPersonExpanded_4_0-4.0.pdf
356813 PHS398_ResearchPlan_5_0-5.0.pdf
356813 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
356813 PHS_Additional_IndirectCosts_2_0-2.0.pdf
356813 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
